A Randomized Clinical Trial of α1-Antitrypsin Augmentation Therapy-Reference-Cited by-同舟云学术

A Randomized Clinical Trial of α1-Antitrypsin Augmentation Therapy

Published:1999-11 Issue:5 Volume:160 Page:1468-1472
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

DIRKSEN ASGER,DIJKMAN JOOP H.,MADSEN FLEMMING,STOEL BEREND,HUTCHISON DUNCAN C. S.,ULRIK CHARLOTTE S.,SKOVGAARD LENE T.,KOK-JENSEN AXEL,RUDOLPHUS ARJAN,SEERSHOLM NIELS,VROOMAN HENRI A.,REIBER JOHAN H. C.,HANSEN NIELS C.,HECKSCHER THOMAS,VISKUM KAJ,STOLK JAN

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference18 articles.

1. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency

2. Decline in pulmonary function in patients with α1-antitrypsin deficiency

3. α1-Antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z

4. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

5. Typing of genetic variants of alpha 1-antitrypsin by electrofocusing.

Cited by 419 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT Chest Imaging Using Normalized Join-Count: Predicting Emphysema Progression in the CanCOLD Study;Radiology;2024-07-01

2. Assessing the efficacy of Alpha1-Proteinase inhibitor (human) augmentation therapy for Alpha1-Antitrypsin deficiency – Related emphysema: Challenges and opportunities;Heliyon;2024-06

3. Alpha-1-Antitrypsin-Mangel;Die Innere Medizin;2024-05-24

4. Antitrypsin deficiency: still more to learn about the lung after 60 years;ERJ Open Research;2024-05-09

5. Classifying Future Healthcare Utilization in COPD Using Quantitative CT Lung Imaging and Two-Step Feature Selection via Sparse Subspace Learning with the CanCOLD Study;Academic Radiology;2024-04